The first and only treatment for the disabling skin condition prurigo nodularis has been approved by the Food and Drug Administration in a development a D.C. dermatologist calls “huge.”
Prurigo nodularis is a persistent condition that causes itching so intense that it disrupts sleep. It can prompt so much scratching that skin starts to bleed; it results in thick skin lesions called nodules, which can cover almost the entire body.
“The impact of prurigo nodularis on quality of life is one of the highest among inflammatory skin diseases and can negatively affect mental health, activities of daily living and social interactions,” said Dr. Adam Friedman, professor and chair of dermatology at The George Washington University School of Medicine and Health Sciences.
